Posted On: 12/01/2014 4:24:50 PM
Post# of 30066
I think Gerald's comments regarding Eltoprazine being allowed to go straight to Phase 3 were regarding ADHD, based on the data from the Elto LID phase 2b trial. That is what my son thinks from listening to the CC again. Gerald said it quickly, but I think that's correct.
In 2016 we could have 3 phase 3 trials going on: 1 for ADHD and 2 concurrent ones for LID (according to Dr. Lowe). Phase 3s are pretty expensive so I'd imagine we'd partner on Eltoprazine in 2016. That could be nice having both indications in phase 3.
2016 will also be the year we do a phase 1/2 trial for RP. A phase 2/3 could happen in early 2017 and we could partner on that as well.
So I am very confident that 18 to 24 months from now will be nice, but I'm in need of better performance in the next few weeks and months.
In 2016 we could have 3 phase 3 trials going on: 1 for ADHD and 2 concurrent ones for LID (according to Dr. Lowe). Phase 3s are pretty expensive so I'd imagine we'd partner on Eltoprazine in 2016. That could be nice having both indications in phase 3.
2016 will also be the year we do a phase 1/2 trial for RP. A phase 2/3 could happen in early 2017 and we could partner on that as well.
So I am very confident that 18 to 24 months from now will be nice, but I'm in need of better performance in the next few weeks and months.
(0)
(0)
